# Ioannis Sapountzis

> Ioannis Sapountzis is a grant investor at Boehringer Ingelheim backing Life Science. See 1 investments, check sizes, portfolio and contact details. Updated…

- Type: Angel Investor
- Fund: [Boehringer Ingelheim](https://shizune.co/investors/profile/boehringer-ingelheim)
- Total investments: 1
- Last investment: Jul 2020
- Lead investor: 100%
- Last updated: Aug 2026

Ioannis Sapountzis is a grant investor at Boehringer Ingelheim focused on Life Science and Therapeutics. Ioannis Sapountzis

## Contacts

5 contacts available for Ioannis Sapountzis: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/ioannis-sapountzis-bde7?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Proxygen | Proxygen is reshaping the druggable space. Their company harnesses technology and know-how to exploit this potential, thereby redefining the borders of the druggable target space. They developed rational discovery assays that, for the first time, enabled the identification and development of novel glue degraders at scale, putting them at theforefront of charting this unexplored chemical space. |  | Grant | Jul 31, 2020 |  |

1 of 1 investments shown.

## About Boehringer Ingelheim

VC Fund · Ingelheim Am Rhein, Germany

Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing, and marketing pharmaceuticals that improve health and quality of life. Our businesses comprise Prescription Medicine, Animal Health, and Biopharmaceuticals.

5 contacts available at Boehringer Ingelheim.

| Name | Title | Profile |
| --- | --- | --- |
| Anjan Chatterjee | Corporate Vice President | https://shizune.co/investors/profile/anjan-chatterjee-2 |
| Christian Eckermann | SVP, Head of Biopharma Austria | https://shizune.co/investors/profile/christian-eckermann |
| Ioannis Sapountzis | Global Head BD&L | https://shizune.co/investors/profile/ioannis-sapountzis-bde7 |
| Jan Cassen Kraus | Head of Supply Chain Management | https://shizune.co/investors/profile/jan-cassen-kraus |
| Klaus-Peter Kammerer | Global Clinical Program Leader | https://shizune.co/investors/profile/klaus-peter-kammerer |

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does Ioannis Sapountzis invest in?

Ioannis Sapountzis invests primarily in Life Science, Therapeutics and Biotechnology startups, most often at Grant stage. Most of the 1 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ioannis Sapountzis?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Ioannis Sapountzis last invest?

The most recent investment recorded for Ioannis Sapountzis closed in Jul 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co